PROVIDER PROFILE · NPI 1821300039

Sao JiralerspongM.D., PH.D.

Hematology-OncologyHouston, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$826

Peer benchmark

Total Medicare services vs. 613 Hematology-Oncology providers in TX — bottom quintile (cohort median 2,625).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$1K

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Letrozole35 claims

Anastrozole24 claims

QUALITY · MIPS · 2024

Final MIPS score

93.3

Quality

74.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

0.77%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Sao Jiralerspong's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
HARRIS COUNTY HOSPITAL DISTRICT	36	235
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	16	56
Julie Nangia Hematology-Oncology · Houston, TX	13	40
Mothaffar Rimawi Hematology-Oncology · Houston, TX	13	29

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history